CV Sciences Inc

For the period ended Mar 31, 2024. Filed May 15, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 15, 2024

CVSIStored price and day change unavailable

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Cash Flows

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(in thousands)

	For the Three Months Ended March 31,
	2024	2023
OPERATING ACTIVITIES
Net income (loss)	$(628)	$5,706
Adjustments to reconcile net income (loss) to net cash flows provided by (used in) operating activities:
Depreciation and amortization	63	59
Stock-based compensation	30	118
Note discount and interest expense	—	100
Non-cash lease expense, net	28	26
Benefit from reversal of accrued payroll tax (Note 12)	—	(6,171)
Other	108	59
Change in operating assets and liabilities:
Accounts receivable, net	(70)	102
Inventory	(102)	37
Prepaid expenses and other	109	1,087
Accounts payable and accrued expenses	(56)	(148)
Net cash flows provided by (used in) operating activities	(518)	975
FINANCING ACTIVITIES
Repayment of note payable	(50)	(764)
Repayment of unsecured debt	(86)	(108)
Net cash flows used in financing activities	(136)	(872)
Effect of exchange rate changes on cash	(1)	—
Net increase (decrease) in cash	(655)	103
Cash, beginning of period	1,317	611
Cash, end of period	$662	$714
Supplemental cash flow disclosure:
Interest paid	$4	$3
Income taxes paid	$6	$—
Supplemental disclosures of non-cash transactions:
Services paid with common stock	$62	$—

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.